Hindcon Chemicals Limited has informed the Exchange regarding 'Annual Report of the Company for fy 2024-25'.
HINDCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindcon Chemicals has filed its Annual Report for FY 2024-25, reporting a 7.68% decline in revenue to ₹58.55 Cr from ₹63.42 Cr in FY24, driven by lower product realisations and heightened competition. EBITDA fell 29.85% to ₹6.25 Cr, with margins contracting by 337 basis points due to pricing pressure, higher raw material costs, and a one-time write-off of outstanding dues from a Jaypee Group company. The company maintained a conservative balance sheet with debt-equity ratio improving to 0.02 from 0.03, and its manufacturing facility operated at 45.05% of installed capacity. On the positive side, the company is diversifying into resin capsule manufacturing, with sample approvals received and a new production line expected to commission in Q2 of the current financial year. The AGM is scheduled for September 23, 2025, and the company is optimistic about growth driven by India's infrastructure spending of ₹11.21 trillion for FY 2025-26.
Mixed signals for shareholders: revenue and profitability declined notably in FY25, but the new resin capsule venture and India's strong infrastructure pipeline offer growth potential. The AGM on September 23, 2025 will be a key event for investors to assess management's recovery plan and margin outlook.